questionsmedicales.fr
Virus
Virus à ARN
Virus à ARN double brin
Reoviridae
Orbivirus
Virus Palyam
Virus Palyam : Questions médicales fréquentes
Termes MeSH sélectionnés :
Cancer-Associated Fibroblasts
Diagnostic
5
Tests de laboratoire
Virus Palyam
Culture virale
Virus Palyam
Symptômes
5
Variabilité des symptômes
Virus Palyam
Complications
Virus Palyam
Temps d'incubation
Virus Palyam
Prévention
5
Moustiquaires
Virus Palyam
Traitements
5
Antibiotiques
Virus Palyam
Complications
5
Complications
Virus Palyam
Fréquence des complications
Virus Palyam
Traitement des complications
Virus Palyam
Récupération
Virus Palyam
Facteurs de risque
Virus Palyam
Facteurs de risque
5
Facteurs de risque
Virus Palyam
Personnes âgées
Virus Palyam
Immunodépression
Virus Palyam
Occupations à risque
Virus Palyam
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virus Palyam : Questions médicales les plus fréquentes",
"headline": "Virus Palyam : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virus Palyam : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-10",
"dateModified": "2025-02-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virus Palyam"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Orbivirus",
"url": "https://questionsmedicales.fr/mesh/D018163",
"about": {
"@type": "MedicalCondition",
"name": "Orbivirus",
"code": {
"@type": "MedicalCode",
"code": "D018163",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "B04.820.223.719.550"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Virus Palyam",
"alternateName": "Palyam Virus",
"code": {
"@type": "MedicalCode",
"code": "D030081",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Duncan R Smith",
"url": "https://questionsmedicales.fr/author/Duncan%20R%20Smith",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com."
}
},
{
"@type": "Person",
"name": "Atitaya Hitakarun",
"url": "https://questionsmedicales.fr/author/Atitaya%20Hitakarun",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Nitwara Wikan",
"url": "https://questionsmedicales.fr/author/Nitwara%20Wikan",
"affiliation": {
"@type": "Organization",
"name": "Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand."
}
},
{
"@type": "Person",
"name": "Sittiruk Roytrakul",
"url": "https://questionsmedicales.fr/author/Sittiruk%20Roytrakul",
"affiliation": {
"@type": "Organization",
"name": "National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand."
}
},
{
"@type": "Person",
"name": "Ronaldo Mohana-Borges",
"url": "https://questionsmedicales.fr/author/Ronaldo%20Mohana-Borges",
"affiliation": {
"@type": "Organization",
"name": "Laboratory of Structural Biotechnology and Bioengineering, Biophysics Institute Carlos Chagas Filho, Lab C0-36ss, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. mohana@biof.ufrj.br."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Identification of cancer-associated fibroblasts subtypes in prostate cancer.",
"datePublished": "2023-03-24",
"url": "https://questionsmedicales.fr/article/37033924",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1133160"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of cancer-associated fibroblasts in tumorigenesis of gastric cancer.",
"datePublished": "2022-10-16",
"url": "https://questionsmedicales.fr/article/36244987",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-022-05320-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts promote malignant phenotypes of prostate cancer cells via autophagy : Cancer-associated fibroblasts promote prostate cancer development.",
"datePublished": "2023-03-31",
"url": "https://questionsmedicales.fr/article/37000314",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10495-023-01828-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma.",
"datePublished": "2022-10-25",
"url": "https://questionsmedicales.fr/article/36284087",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41419-022-05351-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?",
"datePublished": "2023-05-11",
"url": "https://questionsmedicales.fr/article/37170098",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12964-023-01093-5"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Virus",
"item": "https://questionsmedicales.fr/mesh/D014780"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012328"
},
{
"@type": "ListItem",
"position": 4,
"name": "Virus à ARN double brin",
"item": "https://questionsmedicales.fr/mesh/D000086122"
},
{
"@type": "ListItem",
"position": 5,
"name": "Reoviridae",
"item": "https://questionsmedicales.fr/mesh/D012087"
},
{
"@type": "ListItem",
"position": 6,
"name": "Orbivirus",
"item": "https://questionsmedicales.fr/mesh/D018163"
},
{
"@type": "ListItem",
"position": 7,
"name": "Virus Palyam",
"item": "https://questionsmedicales.fr/mesh/D030081"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virus Palyam - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virus Palyam",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virus Palyam",
"description": "Comment diagnostiquer une infection par le virus Palyam ?\nQuels tests sont utilisés pour le virus Palyam ?\nLes symptômes aident-ils au diagnostic ?\nLe virus Palyam est-il identifiable par culture ?\nY a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Cancer-Associated+Fibroblasts#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virus Palyam",
"description": "Quels sont les symptômes courants du virus Palyam ?\nLes symptômes varient selon les individus ?\nLe virus Palyam cause-t-il des complications graves ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques aux enfants ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Cancer-Associated+Fibroblasts#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virus Palyam",
"description": "Comment prévenir l'infection par le virus Palyam ?\nLes vaccins existent-ils pour le virus Palyam ?\nLes mesures d'hygiène aident-elles à prévenir l'infection ?\nLes moustiquaires sont-elles efficaces contre le virus Palyam ?\nLes voyages dans certaines zones augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Cancer-Associated+Fibroblasts#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virus Palyam",
"description": "Quel est le traitement principal pour le virus Palyam ?\nLes antibiotiques sont-ils efficaces contre le virus Palyam ?\nDes antiviraux sont-ils disponibles pour ce virus ?\nComment gérer les symptômes du virus Palyam ?\nLe repos est-il recommandé lors d'une infection ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Cancer-Associated+Fibroblasts#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virus Palyam",
"description": "Quelles sont les complications possibles du virus Palyam ?\nLes complications sont-elles fréquentes ?\nComment les complications sont-elles traitées ?\nLes complications affectent-elles la récupération ?\nY a-t-il des facteurs de risque pour les complications ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Cancer-Associated+Fibroblasts#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virus Palyam",
"description": "Quels sont les principaux facteurs de risque pour le virus Palyam ?\nLes personnes âgées sont-elles plus à risque ?\nLes voyageurs sont-ils à risque d'infection ?\nLes personnes immunodéprimées sont-elles plus vulnérables ?\nY a-t-il des occupations à risque pour le virus Palyam ?",
"url": "https://questionsmedicales.fr/mesh/D030081?mesh_terms=Cancer-Associated+Fibroblasts#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une infection par le virus Palyam ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests sérologiques et la détection de l'ARN viral par PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le virus Palyam ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et la PCR sont couramment utilisés pour identifier le virus."
}
},
{
"@type": "Question",
"name": "Les symptômes aident-ils au diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes cliniques peuvent orienter le diagnostic, mais ne suffisent pas seuls."
}
},
{
"@type": "Question",
"name": "Le virus Palyam est-il identifiable par culture ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture du virus est difficile et rarement utilisée pour le diagnostic clinique."
}
},
{
"@type": "Question",
"name": "Y a-t-il des marqueurs spécifiques pour le virus Palyam ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anticorps spécifiques peuvent être détectés, mais ils ne sont pas exclusifs au virus."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du virus Palyam ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs musculaires et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon les individus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'intensité et la nature des symptômes peuvent varier d'une personne à l'autre."
}
},
{
"@type": "Question",
"name": "Le virus Palyam cause-t-il des complications graves ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques peuvent survenir, bien que rares."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent apparaître rapidement, généralement dans les 3 à 7 jours après infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux enfants ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent présenter des symptômes similaires, mais souvent moins sévères."
}
},
{
"@type": "Question",
"name": "Comment prévenir l'infection par le virus Palyam ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention inclut l'évitement des piqûres d'insectes et l'utilisation de répulsifs."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour le virus Palyam ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin commercialisé contre le virus Palyam."
}
},
{
"@type": "Question",
"name": "Les mesures d'hygiène aident-elles à prévenir l'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des mesures d'hygiène appropriées peuvent réduire le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces contre le virus Palyam ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'utilisation de moustiquaires peut aider à prévenir les piqûres d'insectes."
}
},
{
"@type": "Question",
"name": "Les voyages dans certaines zones augmentent-ils le risque ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques augmente le risque d'infection par le virus."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour le virus Palyam ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre le virus Palyam ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales comme le Palyam."
}
},
{
"@type": "Question",
"name": "Des antiviraux sont-ils disponibles pour ce virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas d'antiviraux spécifiques pour traiter le virus Palyam."
}
},
{
"@type": "Question",
"name": "Comment gérer les symptômes du virus Palyam ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des symptômes inclut des analgésiques et des antipyrétiques pour la fièvre."
}
},
{
"@type": "Question",
"name": "Le repos est-il recommandé lors d'une infection ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le repos est conseillé pour aider le corps à combattre l'infection."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles du virus Palyam ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent inclure des troubles neurologiques et des syndromes hémorragiques."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications graves sont rares, mais peuvent survenir chez certains patients."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement des complications est symptomatique et peut nécessiter des soins intensifs."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la récupération ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent prolonger le temps de récupération et affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des facteurs de risque pour les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes immunodéprimées ou âgées peuvent avoir un risque accru de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque pour le virus Palyam ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'exposition à des zones endémiques et un système immunitaire affaibli."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent être plus susceptibles de développer des complications."
}
},
{
"@type": "Question",
"name": "Les voyageurs sont-ils à risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyageurs vers des régions où le virus est endémique courent un risque accru."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles plus vulnérables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles ont un risque accru de développer des formes graves de l'infection."
}
},
{
"@type": "Question",
"name": "Y a-t-il des occupations à risque pour le virus Palyam ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les travailleurs en milieu rural ou en contact avec des animaux peuvent être à risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 04/02/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand. duncan_r_smith@hotmail.com.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Salaya, 73170, Thailand.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
National Center for Genetic Engineering and Biotechnology (BIOTEC), National Science and Technology Development Agency, Pathum Thani, 12120, Thailand.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Laboratory of Structural Biotechnology and Bioengineering, Biophysics Institute Carlos Chagas Filho, Lab C0-36ss, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. mohana@biof.ufrj.br.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Biosciences, Mahidol University, Nakhon Pathom, Thailand.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Biotechnology Program, Department of Mathematics and Natural Sciences, BRAC University, Dhaka, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Genetic Engineering and Biotechnology, School of Life Sciences, Shahjalal University of Science and Technology, Sylhet, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Biotechnology and Genetic Engineering, Faculty of Life Sciences, Bangabandhu Sheikh Mujibur Rahman Science and Technology University, Gopalganj, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Biological Sciences, Graduate School of Science, Osaka University, Osaka, Japan.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, AB, Canada.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology and Hygiene, Bangladesh Agricultural University, Mymensingh, Bangladesh.
Publications dans "Virus Palyam" :
2 publications dans cette catégorie
Affiliations :
Aix-Marseille University and Centre National de la Recherche Scientifique and Institut de Microbiology de la Méditerranée; IGS Unité Mixte de Recherche 7256, FR3479, IM2B, 13288 Marseille Cedex 9, France.
Publications dans "Virus Palyam" :
Cancer-associated fibroblasts (CAFs) are one of the most abundant cell types in tumor microenvironment. However, the phenotypic and functional heterogeneities among CAFs have not been sufficiently inv...
We obtained and analyzed the single-cell RNA-sequencing data from 26 hormone-sensitive prostate cancer samples and 8 castration-resistant prostate cancer samples, along with the analysis of bulk-seque...
We identified two major CAFs subtypes with distinct molecular characteristics and biological functions in prostate cancer microenvironment, namely αSMA+ CAV1+ CAFs-C0 and FN1+ FAP+ CAFs-C1. Another si...
In summary, our results identified the presence of heterogeneous CAFs subtypes in prostate cancer microenvironment and the potential of specific CAFs subtype as therapeutic target for castration-resis...
Despite advances in anticancer therapy, the prognosis of gastric cancer (GC) remains unsatisfactory. Research in recent years has shown that the malignant behavior of cancer is not only attributable t...
Dysregulation of autophagy in cancer-associated fibroblasts (CAFs) has been demonstrated to play a role in malignant phenotypes of human tumors. We intended to investigate the function of CAFs autopha...
Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer with a prominent extracellular matrix (ECM) deposition and poor prognosis. High levels of ECM proteins derived from tumour cells reduce the e...
The primary goal of radiotherapy (RT) is to induce cellular damage on malignant cells; however, it is becoming increasingly recognized the important role played by the tumor microenvironment (TME) in ...
Cancer-associated fibroblasts (CAFs) are known to participate in all stages of cancer progression and are increasingly acknowledged to contribute to therapy resistance. Accumulated evidence suggests t...
In this review we present current knowledge on the field of CAFs role in radiotherapy; we discuss the potential tumorigenic functions of radiation-induced senescent fibroblasts and CAFs and we make an...
Papillary thyroid carcinoma (PTC) has a relatively good prognosis, yet there are some invasive PTC cases with worse clinicopathological features and poor outcome. Cancer-associated fibroblasts (CAFs) ...
Primary liver cancer (PLC) includes hepatocellular carcinoma and intrahepatic cholangiocarcinoma and is the sixth most common cancer worldwide with poor prognosis. PLC is characterized by an abundant ...
Cancer-associated fibroblasts (CAFs) are central players in the microenvironment of solid tumors, affecting cancer progression and metastasis. CAFs have diverse phenotypes, origins and functions and c...
The characteristics of a tumor are largely determined by its interaction with the surrounding micro-environment (TME). TME consists of both cellular and non-cellular components. Cancer-associated fibr...
Fibroblasts have been derived from Benign Prostatic Hyperplasia (BPH) and prostate cancer. RNA from these has been used to perform a transcriptome analysis in order to get a comparative profile of nor...
The study has identified 818 differentially expressed mRNAs and 17 lincRNAs between normal and cancer-associated fibroblasts. Also, 15 potential lincRNA-miRNA-mRNA combinations have been identified wh...
This study identified differentially expressed markers between normal and cancer-associated fibroblasts that would help in targeted therapy against CAFs/derived factors, in combination with convention...
The tumor microenvironment is one of the important drivers of tumor development. Cancer-associated fibroblasts (CAFs) are a major component of the tumor stroma and actively participate in tumor develo...